PharmaCyte Biotech, Inc.
PMCB- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001157075
No open-market purchases or sales by PharmaCyte Biotech, Inc. insiders were filed in the last 90 days; 32 institutions reported holding it in 13F filings for Q2 2026, worth $586.2K in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by PharmaCyte Biotech, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for PharmaCyte Biotech, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Walker Wayne Remell | Director | 20,625 | Jul 17, 2026 | 2 |
| Abecassis Michael M | Director | 22,292 | Jul 17, 2026 | 2 |
| Schechter Jonathan | Director | 192,500 | Jul 17, 2026 | 3 |
| Weinstein Robert | Director | 41,250 | Jul 17, 2026 | 2 |
| Silverman Joshua | CEO and President | 416,250 | Jan 7, 2026 | 2 |
| Trujillo Carlos | Chief Financial Officer | – | Nov 22, 2023 | 0 |
| Allen Daniel | Director | – | Dec 30, 2022 | 0 |
| Farb Daniel Stuart | Director | – | Dec 30, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 7, 2026 (view filing) | Jan 5-7 | 2 days | Silverman JoshuaCEO and President | PPurchase | +100.0K | $0.803 | +$80.3K | +31.6%416.3K after | 3 lots |
| Jan 7, 2026 (view filing) | Jan 5-7 | 2 days | Schechter JonathanDirector | PPurchase | +60.0K | $0.8033 | +$48.2K | +45.3%192.5K after | 3 lots |